PSTX Overview

Roche's Acquisition of Poseida Therapeutics: Roche plans to complete its acquisition of U.S. biopharmaceutical company Poseida Therapeutics for approximately $1.5 billion, having accepted nearly 65 million shares, which represents 66% of Poseida's stock.

Strategic Expansion in Cancer Treatment: The acquisition will enhance Roche's development pipeline by adding allogeneic CAR-T cell therapies aimed at treating various blood cancers and autoimmune diseases, as Poseida becomes a wholly owned subsidiary.

NASDAQ 100 After Hours Performance: The NASDAQ 100 is up 28.17 points to 21,201.21 with a total after-hours trading volume of 186,500,748 shares.

Most Active Stocks: Sana Biotechnology leads with a significant increase, while other notable stocks include AT&T, NVIDIA, and Intel, with varying performance in after-hours trading.

Investigation of Poseida Therapeutics Sale: Halper Sadeh LLC is investigating the fairness of Poseida Therapeutics' sale to Roche Holdings for $9.00 per share, plus contingent payments, focusing on potential violations of federal securities laws and fiduciary duties by Poseida's board.

Legal Rights for Shareholders: The law firm encourages Poseida shareholders to explore their legal rights regarding the transaction, which may include seeking increased compensation or additional disclosures about the merger.

Law Firm Investigations: Monteverde & Associates PC is investigating several proposed mergers involving companies like Profire Energy, Poseida Therapeutics, Arch Resources, and Barnes Group, with specific tender offer deadlines for shareholders to act upon.

Shareholder Rights: The firm emphasizes its successful track record in recovering money for shareholders and encourages those affected by the mergers to seek free information and assistance regarding their rights.

Investigation of Companies: Halper Sadeh LLC is investigating potential violations of federal securities laws and fiduciary duties related to the sales of several companies, including Penns Woods Bancorp, Revance Therapeutics, Barnes Group Inc., and Poseida Therapeutics.

Shareholder Rights and Legal Support: The firm offers free consultations to shareholders regarding their legal rights and options, aiming to seek increased consideration or other benefits for them in these transactions.

Investigation of Companies: Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the sales of several companies, including Barnes Group Inc., Poseida Therapeutics, Adams Resources & Energy, and Profire Energy.

Legal Rights for Shareholders: The firm encourages shareholders from these companies to contact them for free consultations regarding their legal rights and options, emphasizing that they operate on a contingent fee basis.